Voiding Dysfunction
25
3
3
11
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.0%
1 terminated out of 25 trials
91.7%
+5.2% vs benchmark
4%
1 trials in Phase 3/4
18%
2 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (25)
How the Method of Bladder Emptying After Epidural Placement in Labor Affects Postpartum Voiding
Association Between Qmax/eGFR Ratio and LUTS Severity in Men Over 40
Uroflowmetry and IPSS Factors Influencing Surgical Decision
Uroflowmetry Curve Types and IPSS in Men With LUTS
Prevalence of Functional Lower Urinary Tract Voiding Dysfunction in School-Aged Children
Treatment Outcomes Under a Standardized Treatment Protocol in Patients Suffered Substance Abuse Related Voiding Dysfunction
HOme PElvic Floor Improvement Trainer Trial
Artificial Intelligence-Based Analysis of Uroflowmetry Patterns in Children: a Machine Learning Perspective
The Role of Timed Awakening in Treatment of Enuresis
Efficacy of Alpha-blockers (Tamsulosin) in the Treatment of Symptomatic Dysuria in Multiple Sclerosis in Women
Smart-phone Application Versus Conventional Paper for the Documentation of Voiding Dysfunction in Children
Evaluating the Optimal Volume Voided for Passage of a Backfill-Assisted Voiding Trial Following Urogynecologic Surgery
Brain Targets in Patients With Bladder Emptying Difficulties
Patient Self Measurement of Post-Void Residual Bladder Volume (PVR) Using Ultrasound
The Measurement of Bladder Impedance and Heart Rate During Urodynamic Study
Urodynamics for Prostate Surgery Trial; Randomised Evaluation of Assessment Methods
Rigid Versus Flexible Cystoscopy in Women
Randomized Controlled Trial of Cystocele Plication Risks ("CPR Trial"): A Pilot Study
A Follow-net Investigation of a Randomised Study of Cystoscopy and Urethral Dilatation Versus Cystoscopy Alone in Women With Overactive Bladder Syndrome and Impaired Voiding
Efficacy and Safety of Alfuzosin for the Treatment of Voiding Dysfunction in Female